Search Results 1151-1160 of 3431 for backwatersare
... back or does not respond to treatment. Immunotoxins, such as inotuzumab ozogamicin, are antibodies linked to a toxic substance and may help find cancer ...
Combination positron emission tomography/computed axial tomography (PET/CT) is a particularly sensitive, accurate scanning method that may improve researchers' ...
... back after a period of improvement (recurrent). Natural History Evaluation Among Female Breast Cancer Survivors with Endocrine Therapy-Induced Alopecia.
... back or does not respond to treatment. A virus, called VSV-hIFNbeta-NIS, which has been changed in a certain way, may be able to kill cancer cells without ...
It also may be used for advanced cancers that have spread to other parts of the body or cancer that has come back after treatment. Palliative care. Palliative ...
This randomized, placebo-controlled, double-blind, parallel-arm study will evaluate the safety and tolerability of at least two dose levels of intravenous (IV) ...
About this study. The purpose of this study is to compare the cardiovascular function in young women (<46 years) following bilateral oophorectomy who are ...
The Bone Injury and Repair Lab of Abhishek Chandra, Ph.D., at Mayo Clinic identifies novel pathways targeting bone-resorbing osteoclasts without affecting ...
... back (relapsed). Drugs used in chemotherapy regimens such as UH-3 (vincristine, doxorubicin, cyclophosphamide, carboplatin, etoposide, and irinotecan) and ...
... back (recurrent) or that does not respond to treatment (refractory). Onvansertib is a drug that binds to and inhibits an enzyme called PLK1, preventing ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make your tax-deductible gift and be a part of the cutting-edge research and care that's changing medicine.